Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
出版年份 2022 全文链接
标题
Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-08-23
DOI
10.3389/fimmu.2022.972930
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study
- (2022) Masoumeh Azimirad et al. Journal of Inflammation Research
- Transient expression of an scFvG8 antibody in plants and characterization of its effects on the virulence factor pthA of Xanthomonas citri subsp. citri
- (2022) Hamideh Raeisi et al. TRANSGENIC RESEARCH
- Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments
- (2021) Francesco Nannini et al. mAbs
- Antibodies to watch in 2021
- (2021) Hélène Kaplon et al. mAbs
- Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
- (2021) Jinsha Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diagnosis and Treatment of Metastatic Colorectal Cancer
- (2021) Leah H. Biller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oral Immunotherapy with Human Secretory IgA Improves Survival in the Hamster Model of Clostridioides difficile Infection
- (2021) Estelle F Chiari et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody display technologies: selecting the cream of the crop
- (2021) Bernhard Valldorf et al. BIOLOGICAL CHEMISTRY
- A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes
- (2021) Yu Guo et al. Nature Communications
- Tralokinumab: First Approval
- (2021) Sean Duggan DRUGS
- Expression of antibody fragments in Saccharomyces cerevisiae strains evolved for enhanced protein secretion
- (2021) Yanyan Wang et al. Microbial Cell Factories
- Large Clostridial Toxins: Mechanisms and Roles in Disease
- (2021) Kathleen E. Orrell et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
- (2021) Kristian Daniel Ralph Roth et al. Frontiers in Cellular and Infection Microbiology
- High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics
- (2021) Yuan Wang et al. Science Advances
- European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
- (2021) Joffrey van Prehn et al. CLINICAL MICROBIOLOGY AND INFECTION
- How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
- (2021) Masoumeh Azimirad et al. Frontiers in Medicine
- High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics
- (2020) Annabelle Gérard et al. NATURE BIOTECHNOLOGY
- Change of Amino Acid Residues in Idiotypic Nanobodies Enhanced the Sensitivity of Competitive Enzyme Immunoassay for Mycotoxin Ochratoxin A in Cereals
- (2020) Caixia Zhang et al. Toxins
- Discrete analysis of camelid variable domains: sequences, structures, and in-silico structure prediction
- (2020) Akhila Melarkode Vattekatte et al. PeerJ
- Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
- (2020) Erik R Dubberke et al. Open Forum Infectious Diseases
- Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
- (2020) Hilal Ahmed Parray et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap
- (2020) Yacine Bounab et al. Nature Protocols
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2
- (2020) Alex Renn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- How single-cell immunology is benefiting from microfluidic technologies
- (2020) Fabien C. Jammes et al. Microsystems & Nanoengineering
- Development of a double-recombinant antibody sandwich ELISA for quantitative detection of epsilon toxoid concentration in inactivated Clostridium perfringens vaccines
- (2020) Maryam Alibeiki et al. BMC Veterinary Research
- Animal-free alternatives and the antibody iceberg
- (2020) Alison Gray et al. NATURE BIOTECHNOLOGY
- A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models
- (2020) April K. Roberts et al. Frontiers in Microbiology
- Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
- (2020) Mohamed A. Alfaleh et al. Frontiers in Immunology
- Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
- (2020) Masoumeh Azimirad et al. Journal of Inflammation Research
- Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins
- (2020) Hye-Yeon Kim et al. BIOSENSORS & BIOELECTRONICS
- Emapalumab: First Global Approval
- (2019) Zaina T. Al-Salama DRUGS
- Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model
- (2019) Hans-Jürgen Heidebrecht et al. Toxins
- Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics
- (2019) Michael A. Asensio et al. mAbs
- Nanobody: outstanding features for diagnostic and therapeutic applications
- (2019) J.-Pablo Salvador et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Clostridium difficile infection: review
- (2019) Jacek Czepiel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation
- (2019) Chia Chiu Lim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phage display screening of therapeutic peptide for cancer targeting and therapy
- (2019) Phei Er Saw et al. Protein & Cell
- Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland
- (2019) Jarmo Oksi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development
- (2019) Xun Gui et al. Cancer Immunology Research
- Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice
- (2019) Godakova et al. Toxins
- Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy
- (2019) Xiang-Min Tong et al. Journal for ImmunoTherapy of Cancer
- Immunogenicity and Protection from Receptor-Binding Domains of Toxins as Potential Vaccine Candidates for Clostridium difficile
- (2019) Deyan Luo et al. Vaccines
- Why recombinant antibodies — benefits and applications
- (2019) Koli Basu et al. CURRENT OPINION IN BIOTECHNOLOGY
- Phage display: an important tool in the discovery of peptides with anti-HIV activity
- (2018) Ronaldo Souza Lopes et al. BIOTECHNOLOGY ADVANCES
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
- (2018) Dale N Gerding et al. CLINICAL INFECTIOUS DISEASES
- Microbiologic factors affecting Clostridium difficile recurrence
- (2018) C.H. Chilton et al. CLINICAL MICROBIOLOGY AND INFECTION
- Understanding Clostridium difficile Colonization
- (2018) Monique J. T. Crobach et al. CLINICAL MICROBIOLOGY REVIEWS
- Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting
- (2018) Simon W. Lam et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Generation and screening of efficient neutralizing single domain antibodies (VHHs) against the critical functional domain of anthrax protective antigen (PA)
- (2018) Abbas Shali et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Sensitive electrochemical immunosensor for citrus bacterial canker disease detection using fast Fourier transformation square-wave voltammetry method
- (2018) Hedieh Haji-Hashemi et al. JOURNAL OF ELECTROANALYTICAL CHEMISTRY
- Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
- (2018) Robert J. Kreitman et al. LEUKEMIA
- Microfluidic single-cell technology in immunology and antibody screening
- (2018) Yu Fen Samantha Seah et al. MOLECULAR ASPECTS OF MEDICINE
- Functional interrogation and mining of natively paired human VH:VL antibody repertoires
- (2018) Bo Wang et al. NATURE BIOTECHNOLOGY
- Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody
- (2018) Traian Sulea et al. Scientific Reports
- Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection
- (2018) Séverine Péchiné et al. Frontiers in Microbiology
- Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection
- (2018) Beatrix Förster et al. Frontiers in Microbiology
- Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
- (2018) Juan C. Almagro et al. Frontiers in Immunology
- Next-Generation Sequencing of Antibody Display Repertoires
- (2018) Romain Rouet et al. Frontiers in Immunology
- Caplacizumab: First Global Approval
- (2018) Sean Duggan DRUGS
- Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
- (2018) Jung Hoon Song et al. Gut and Liver
- Ribosome Display: A Potent Display Technology used for Selecting and Evolving Specific Binders with Desired Properties
- (2018) Ruowei Li et al. MOLECULAR BIOTECHNOLOGY
- Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains
- (2018) Greg Hussack et al. PLoS One
- Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of Clostridioides difficile
- (2018) Viola Fühner et al. Frontiers in Microbiology
- Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition
- (2018) Mathieu Dondelinger et al. Frontiers in Immunology
- Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile
- (2018) Carolyn D. Alonso et al. Infection and Drug Resistance
- Utilization of Multi-Immunization and Multiple Selection Strategies for Isolation of Hapten-Specific Antibodies from Recombinant Antibody Phage Display Libraries
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics
- (2017) Adam S. Adler et al. mAbs
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designing Human Antibodies by Phage Display
- (2017) André Frenzel et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
- (2017) Ivana Jovčevska et al. Oncotarget
- Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model
- (2017) Yi-Wen Liu et al. Frontiers in Microbiology
- New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
- (2017) Isabel Corraliza-Gorjón et al. Frontiers in Immunology
- Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
- (2017) Hongyan Liu et al. Frontiers in Immunology
- Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
- (2017) Peter Bannas et al. Frontiers in Immunology
- Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative
- (2017) Melanie L. Hutton et al. Scientific Reports
- Isolation of recombinant antibodies directed against surface proteins of Clostridium difficile
- (2016) Ali Nazari Shirvan et al. BRAZILIAN JOURNAL OF MICROBIOLOGY
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- (2016) Nicole L. Kallewaard et al. CELL
- Ixekizumab: First Global Approval
- (2016) Anthony Markham DRUGS
- Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
- (2016) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Breakthroughs in the treatment and prevention of Clostridium difficile infection
- (2016) Larry K. Kociolek et al. Nature Reviews Gastroenterology & Hepatology
- Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model
- (2016) Hongyu Qiu et al. PLoS One
- Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers
- (2016) Nicole Bézay et al. VACCINE
- Multivalent pIX phage display selects for distinct and improved antibody properties
- (2016) Lene S. Høydahl et al. Scientific Reports
- Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
- (2016) Stefano Di Bella et al. Toxins
- Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice fromClostridium difficileinfection
- (2016) Zhiyong Yang et al. Pathogens and Disease
- Clostridium difficile infection
- (2016) Wiep Klaas Smits et al. Nature Reviews Disease Primers
- Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease
- (2015) Hiba Kandalaft et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model
- (2015) Natalie G. Anosova et al. Clinical and Vaccine Immunology
- Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies
- (2015) Kasper Krogh Andersen et al. INFECTION AND IMMUNITY
- Bispecific antibodies and their applications
- (2015) Gaowei Fan et al. Journal of Hematology & Oncology
- Alternative molecular formats and therapeutic applications for bispecific antibodies
- (2015) Christoph Spiess et al. MOLECULAR IMMUNOLOGY
- The role of flagella in Clostridium difficile pathogenicity
- (2015) Emma Stevenson et al. TRENDS IN MICROBIOLOGY
- History of passive antibody administration for prevention and treatment of infectious diseases
- (2015) Barney S. Graham et al. Current Opinion in HIV and AIDS
- Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus
- (2015) Marc Monot et al. Scientific Reports
- Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT
- (2015) Mandy Unger et al. Scientific Reports
- Novel approaches to treatingClostridium difficile-associated colitis
- (2015) David Padua et al. Expert Review of Gastroenterology & Hepatology
- Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
- (2015) B. Boyerinas et al. Cancer Immunology Research
- Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance
- (2015) Priscilla Johanesen et al. Genes
- Bezlotoxumab Alone and With Actoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients on Standard of Care Antibiotics: Integrated Results of 2 Phase 3 Studies (MODIFY I and MODIFY II)
- (2015) Mark Wilcox et al. Open Forum Infectious Diseases
- The Clostridium difficile Protease Cwp84 Modulates both Biofilm Formation and Cell-Surface Properties
- (2015) Véronique Pantaléon et al. PLoS One
- Mutational approaches to improve the biophysical properties of human single-domain antibodies
- (2014) Dae Young Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Multi-Specific Antibodies for Cancer Immunotherapy
- (2014) Ron D. Jachimowicz et al. BIODRUGS
- Antibodies for Treatment of Clostridium difficile Infection
- (2014) David P. Humphreys et al. Clinical and Vaccine Immunology
- Clostridium difficileinfection: molecular pathogenesis and novel therapeutics
- (2014) Ardeshir Rineh et al. Expert Review of Anti-Infective Therapy
- Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
- (2014) Zhiyong Yang et al. INFECTION AND IMMUNITY
- Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
- (2014) Howard Sofen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody
- (2014) Jon A. Kenniston et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Multivalent, Single-Domain Antibody Targeting TcdA and TcdB Prevents Fulminant Clostridium difficile Infection in Mice
- (2014) Zhiyong Yang et al. JOURNAL OF INFECTIOUS DISEASES
- Hyperimmune Bovine Colostrum as a Novel Therapy to Combat Clostridium difficile Infection
- (2014) J. K. Sponseller et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody Phage Display: Technique and Applications
- (2014) Christoph M. Hammers et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications
- (2014) Junrong Yan et al. Journal of Translational Medicine
- The promise and challenge of high-throughput sequencing of the antibody repertoire
- (2014) George Georgiou et al. NATURE BIOTECHNOLOGY
- Co-Expression of Anti-Rotavirus Proteins (Llama VHH Antibody Fragments) in Lactobacillus: Development and Functionality of Vectors Containing Two Expression Cassettes in Tandem
- (2014) Gökçe Günaydın et al. PLoS One
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- Vaccines against Clostridium difficile
- (2014) Rosanna Leuzzi et al. Human Vaccines & Immunotherapeutics
- A clinical and epidemiological review of non-toxigenic Clostridium difficile
- (2013) Mukil Natarajan et al. ANAEROBE
- Ranibizumab: The First Vascular Endothelial Growth Factor Inhibitor Approved for the Treatment of Diabetic Macular Edema
- (2013) Kirk E Evoy et al. ANNALS OF PHARMACOTHERAPY
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes
- (2013) Hon Wai Koon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficile TcdA and TcdB with High Levels ofIn VitroPotency ShowsIn VivoProtection in a Hamster Infection Model
- (2013) Nicola L. Davies et al. Clinical and Vaccine Immunology
- A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2
- (2013) Jacqueline M. Tremblay et al. INFECTION AND IMMUNITY
- Nanobodies as novel agents for disease diagnosis and therapy
- (2013) Christina G. Siontorou International Journal of Nanomedicine
- Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
- (2013) Abhishek Deshpande et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B fromClostridium difficile
- (2013) Tomohiko Murase et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Drugs derived from phage display
- (2013) Andrew E Nixon et al. mAbs
- Nanobodies and their potential applications
- (2013) Gholamreza Hassanzadeh-Ghassabeh et al. Nanomedicine
- Single-cell analysis and sorting using droplet-based microfluidics
- (2013) Linas Mazutis et al. Nature Protocols
- Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile
- (2013) Michelle M. Merrigan et al. PLoS One
- A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications
- (2013) Hannah Byrne et al. TRENDS IN BIOTECHNOLOGY
- Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response
- (2013) Michael Maynard-Smith et al. VACCINE
- Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States
- (2013) Paul M. Stranges et al. VALUE IN HEALTH
- Potent monoclonal antibodies againstClostridium difficiletoxin A elicited by DNA immunization
- (2013) Chunhua Zhang et al. Human Vaccines & Immunotherapeutics
- Expression of Recombinant Antibodies
- (2013) André Frenzel et al. Frontiers in Immunology
- Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance
- (2013) Kathleen Mullane Therapeutic Advances in Chronic Disease
- Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
- (2012) Lawrence J Brandt et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- scFv Antibody: Principles and Clinical Application
- (2012) Zuhaida Asra Ahmad et al. Clinical & Developmental Immunology
- Antimicrobial Activities of Fidaxomicin
- (2012) Ellie J. C. Goldstein et al. CLINICAL INFECTIOUS DISEASES
- Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
- (2012) O. A. Cornely et al. CLINICAL INFECTIOUS DISEASES
- Can we identify patients at high risk of recurrent Clostridium difficile infection?
- (2012) C.P. Kelly CLINICAL MICROBIOLOGY AND INFECTION
- In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa
- (2012) AZMI ADAWI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Antibody Against TcdB, but Not TcdA, Prevents Development of Gastrointestinal and Systemic Clostridium difficile Disease
- (2012) Jennifer Steele et al. JOURNAL OF INFECTIOUS DISEASES
- Protection Against Clostridium difficile Infection With Broadly Neutralizing Antitoxin Monoclonal Antibodies
- (2012) Andre J. Marozsan et al. JOURNAL OF INFECTIOUS DISEASES
- Functional single-cell hybridoma screening using droplet-based microfluidics
- (2012) B. E. Debs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties
- (2012) R. Castoldi et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Phage display—A powerful technique for immunotherapy
- (2012) Justyna Bazan et al. Human Vaccines & Immunotherapeutics
- Structural Consensus among Antibodies Defines the Antigen Binding Site
- (2012) Vered Kunik et al. PLoS Computational Biology
- Integrative Expression System for Delivery of Antibody Fragments by Lactobacilli
- (2011) M. Cruz Martín et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli
- (2011) Kasper Andersen et al. BMC BIOTECHNOLOGY
- Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea
- (2011) Neha Pant et al. Future Microbiology
- Development and Evaluation of an Ovine Antibody-Based Platform for Treatment of Clostridium difficile Infection
- (2011) April Roberts et al. INFECTION AND IMMUNITY
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- Evidence of intravenous immunoglobulin as a critical supportive therapy against Clostridium difficile toxin-mediated lethality in mice
- (2011) T. Saito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Neutralization ofClostridium difficileToxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain
- (2011) Greg Hussack et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic potential of egg yolk antibodies for treating Clostridium difficile infection
- (2011) G. L. Mulvey et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Beyond natural antibodies: the power of in vitro display technologies
- (2011) Andrew R M Bradbury et al. NATURE BIOTECHNOLOGY
- Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
- (2011) Greg Hussack et al. PLoS One
- Differential Binding and Internalization of Clostridium difficile Toxin A by Human Peripheral Blood Monocytes, Neutrophils and Lymphocytes
- (2011) N. Modi et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Chicken scFvs and bivalent scFv-CH fusions directed against HSP65 of Mycobacterium bovis
- (2010) Susan Wemmer et al. BIOLOGICALS
- A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies
- (2010) B. Kuenen et al. CLINICAL CANCER RESEARCH
- Monoclonal antibodies as diagnostics; an appraisal
- (2010) MZ Siddiqui INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Production of Anti-carbohydrate Antibodies by Phage Display Technologies
- (2010) Noriyuki Yuasa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intravenous immunoglobulin for the treatment of severeClostridium difficilecolitis: An observational study and review of the literature
- (2010) Marwan S. Abougergi et al. Journal of Hospital Medicine
- Raxibacumab
- (2010) Sohini Mazumdar mAbs
- Neutralization ofClostridium difficiletoxin A using antibody combinations
- (2010) Stephen J. Demarest et al. mAbs
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multivalent antibodies: when design surpasses evolution
- (2010) Ángel M. Cuesta et al. TRENDS IN BIOTECHNOLOGY
- Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives
- (2010) Greg Hussack et al. Toxins
- Specific immuno capturing of the Staphylococcal superantigen toxic-shock syndrome toxin-1 in plasma
- (2009) Hendrik Adams et al. BIOTECHNOLOGY AND BIOENGINEERING
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model
- (2009) Hamed Laroui et al. GASTROENTEROLOGY
- Antibody-Enhanced, Fc Gamma Receptor-Mediated Endocytosis of Clostridium difficile Toxin A
- (2009) X. He et al. INFECTION AND IMMUNITY
- Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
- (2009) Janusz Wesolowski et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
- (2009) K Vandenbroucke et al. Mucosal Immunology
- Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
- (2009) Brett A. Leav et al. VACCINE
- Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases
- (2008) Changhai Ding EXPERT OPINION ON BIOLOGICAL THERAPY
- Active immunization of hamsters againstClostridium difficileinfection using surface-layer protein
- (2008) Déirdre B. Ní Eidhin et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started